Month: September 2007
-
Forest Labs. v. Ivax Pharms. and Cipla, No. 2007-1059 (Fed. Cir. 2007) In an opinion released today, the Court of Appeals for the Federal Circuit affirmed a district court decision that upheld the validity of Forest Labs’ U.S. Reissue Patent 34,712, which covers (+)-citalopram, the active ingredient in Lexapro. Teva, seeking to market a generic…
-
Novartis announced last week that European regulators have approved its follow-on biologic epoetin alfa, which is biosimilar to J&J’s Eprex. Pharmalot posted this story today about J&J’s reaction. The WSJ Health Blog had this interesting post last week reporting that more clinical trials are now under way in China than in India. Adams Respiratory Therapeutics…
Orange Book Blog 